Evidence map›Paper›PMID 38830728›Full record

ArticleBMJ open ophthalmology2024

Multiple use of preservative-free single dose unit dexamethasone 0.1% eye drops is safe within 24 hours.

Fabienne C Fierz, Silvan Locher, Lucas Bachmann, Philipp B Baenninger, Frank Bochmann, Claude Kaufmann, Irena Mitrovic, Marco Rossi, Michael A Thiel, Jeremy P Howell

Abstract read
In one paragraph

Article in BMJ open ophthalmology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Fabienne C FierzDepartment of Ophthalmology, Cantonal Hospital Lucerne, Lucerne, Switzerland fabienne.fierz@usz.ch.ORCID 0000-0002-2764-0441
Silvan LocherDepartment of Ophthalmology, Cantonal Hospital Lucerne, Lucerne, Switzerland.
Lucas BachmannDepartment of Ophthalmology, Cantonal Hospital Lucerne, Lucerne, Switzerland.
Philipp B BaenningerDepartment of Ophthalmology, Cantonal Hospital Lucerne, Lucerne, Switzerland.
Frank BochmannDepartment of Ophthalmology, Cantonal Hospital Lucerne, Lucerne, Switzerland.
Claude KaufmannDepartment of Ophthalmology, Cantonal Hospital Lucerne, Lucerne, Switzerland.
Irena MitrovicMedical Microbiology, Cantonal Hospital Lucerne, Luzern, Switzerland.
Marco RossiDepartment of Infectiology and Hospital Hygiene, Cantonal Hospital Lucerne, Lucerne, Switzerland.
Michael A ThielDepartment of Ophthalmology, Cantonal Hospital Lucerne, Lucerne, Switzerland.
Jeremy P HowellDepartment of Ophthalmology, Cantonal Hospital Lucerne, Lucerne, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUnpreserved single-dose unit (SDU) eye drops are commonly used to avoid benzalkonium chloride-related toxicity. Although intended for single use, many patients report off-label repeated use of SDUs over a prolonged period. We investigated whether repeated use of dexamethasone 0.1% SDUs in the same patient increases the bacterial contamination rate.

methodsWe prospectively enrolled patients scheduled for inpatient corneal and glaucoma surgery receiving dexamethasone 0.1% SDU four times per day from the same vial. To assess contamination rates, one drop from the vial was cultured immediately after opening the SDU (t0), 10 hours later after four drop applications (t10) and 24 hours after opening without further drop applications (t24). Conjunctival swabs were taken before and after drop application. Contamination rate was assessed with a standard clinical culturing protocol without introducing a positive control.

results110 eyes of 109 patients were evaluated. Drops collected immediately after opening the SDU (t0) were contaminated in 9/110 cultures (8.1%). At t10, 13/110 cultures were contaminated (11.8%; p=0.267) and 11/110 at t24 (10.0%; t24 vs t0; p=1.00). In 5 of 21 cases of contaminated drops at t10 and/or t24, the same isolates were cultured from the initial conjunctival swab and the SDU. In three cases, the same bacterial species was found in consecutive samples.

conclusionThe contamination rate of the SDU did not increase after multiple use within 24 hours. Contamination from fingertip flora was more likely than from ocular surface flora. Reuse of dexamethasone 0.1% SDU in the same patient within 24 hours appears to be safe.

Indexed as

DexamethasoneGlucocorticoidsOphthalmic SolutionsPreservatives, PharmaceuticalAdultAgedAged, 80 and overBacteriaConjunctivaCorneal DiseasesDrug ContaminationFemaleGlaucomaHumansMaleMiddle AgedDexamethasoneGlucocorticoidsOphthalmic SolutionsPreservatives, Pharmaceuticaldiagnostic tests/investigationeye lidsmicrobiologyocular surface

Identifiers

PMID38830728
PMCPMC11331357

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.